Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study

Pollán, 2020, Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study, Lancet, 396, 535, 10.1016/S0140-6736(20)31483-5 Hung, 2020, SARS-CoV-2 shedding and seroconversion among passengers quarantined after disembarking a cruise ship: a case series, Lancet Infect Dis, 20, 1051, 10.1016/S1473-3099(20)30364-9 Long, 2020, Antibody responses to SARS-CoV-2 in patients with COVID-19, Nat Med, 26, 845, 10.1038/s41591-020-0897-1 Caturegli, 2020, Clinical validity of serum antibodies to SARS-CoV-2: a case-control study, Ann Intern Med, 10.7326/M20-2889 Sakurai, 2020, Natural history of asymptomatic SARS-CoV-2 infection, N Engl J Med, 383, 885, 10.1056/NEJMc2013020 Payne, 2020, SARS-CoV-2 infections and serologic responses from a sample of US navy service members—USS Theodore Roosevelt, April 2020, MMWR Morb Mortal Wkly Rep, 69, 714, 10.15585/mmwr.mm6923e4 Sood, 2020, Seroprevalence of SARS-CoV-2-specific antibodies among adults in Los Angeles County, California, on April 10–11, 2020, JAMA, 323, 2425, 10.1001/jama.2020.8279 Bendavid, 2020, COVID-19 antibody seroprevalence in Santa Clara County, California, medRxiv Rosenberg, 2020, Cumulative incidence and diagnosis of SARS-CoV-2 infection in New York, Ann Epidemiol, 48, 23, 10.1016/j.annepidem.2020.06.004 Havers, 2020, Seroprevalence of antibodies to SARS-CoV-2 in six sites in the United States, March 23-May 3, 2020, medRxiv 2019 Peeling, 2020, Serology testing in the COVID-19 pandemic response, Lancet Infect Dis, 20, e245, 10.1016/S1473-3099(20)30517-X Frankel, 2010, Sampling theory, 83 Dong, 2020, An interactive web-based dashboard to track COVID-19 in real time, Lancet Infect Dis, 20, 533, 10.1016/S1473-3099(20)30120-1 Benatia, 2020, Estimating COVID-19 prevalence in the United States: a sample selection model approach, medRxiv Schnurra, 2020, Comparison of the diagnostic sensitivity of SARS-CoV-2 nucleoprotein and glycoprotein-based antibody tests, J Clin Virol, 129, 10.1016/j.jcv.2020.104544 Stringhini, 2020, Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study, Lancet, 396, 313, 10.1016/S0140-6736(20)31304-0 Kolenikov, 2016, Post-stratification or non-response adjustment?, Surv Pract, 9, 1, 10.29115/SP-2016-0014 Holt, 1979, Post stratification, J R Stat Soc [Ser A], 142, 33, 10.2307/2344652 Korn, 1999 Rao, 1981, The analysis of categorical data from complex surveys: chi-squared tests for goodness of fit and independence in two-way tables, J Am Stat Assoc, 76, 221, 10.1080/01621459.1981.10477633 Rao, 1984, On chi-squared tests for multiway contingency tables with cell properties estimated from survey data, Ann Stat, 12, 46, 10.1214/aos/1176346391 Moore, 2008, Availability of recreational resources in minority and low socioeconomic status areas, Am J Prev Med, 34, 16, 10.1016/j.amepre.2007.09.021 Bower, 2014, The intersection of neighborhood racial segregation, poverty, and urbanicity and its impact on food store availability in the United States, Prev Med, 58, 33, 10.1016/j.ypmed.2013.10.010 Alberici, 2020, A report from the Brescia Renal COVID Task Force on the clinical characteristics and short-term outcome of hemodialysis patients with SARS-CoV-2 infection, Kidney Int, 98, 20, 10.1016/j.kint.2020.04.030 Volkova, 2008, Neighborhood poverty and racial differences in ESRD incidence, J Am Soc Nephrol, 19, 356, 10.1681/ASN.2006080934 Crews, 2014, Low income, community poverty and risk of end stage renal disease, BMC Nephrol, 15, 192, 10.1186/1471-2369-15-192 Clarke, 2020, High prevalence of asymptomatic COVID-19 infection in hemodialysis patients detected using serologic screening, J Am Soc Nephrol, 31, 1969, 10.1681/ASN.2020060827 Choi, 2009, White/black racial differences in risk of end-stage renal disease and death, Am J Med, 122, 672, 10.1016/j.amjmed.2008.11.021 Hsu, 2003, Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States, J Am Soc Nephrol, 14, 2902, 10.1097/01.ASN.0000091586.46532.B4 Erickson, 2018, Employment among patients starting dialysis in the United States, Clin J Am Soc Nephrol, 13, 265, 10.2215/CJN.06470617 Bao, 2012, Frailty, dialysis initiation, and mortality in end-stage renal disease, Arch Intern Med, 172, 1071, 10.1001/archinternmed.2012.3020 Edey, 2010, Review article: hepatitis B and dialysis, Nephrology (Carlton), 15, 137, 10.1111/j.1440-1797.2009.01268.x Xu, 2020, Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China, Nat Med, 26, 1193, 10.1038/s41591-020-0949-6 Ward, 2020, Antibody prevalence for SARS-CoV-2 in England following first peak of the pandemic: REACT2 study in 100,000 adults, medRxiv Cowger, 2020, Comparison of weighted and unweighted population data to assess inequities in coronavirus disease 2019 deaths by race/ethnicity reported by the US Centers for Disease Control and Prevention, JAMA Netw Open, 3, 10.1001/jamanetworkopen.2020.16933 Yancy, 2020, COVID-19 and African Americans, JAMA, 323, 1891, 10.1001/jama.2020.6548 Bialek, 2020, Geographic differences in COVID-19 cases, deaths, and incidence—United States, February 12-April 7, 2020, MMWR Morb Mortal Wkly Rep, 69, 465, 10.15585/mmwr.mm6915e4 Sy, 2020, Population density and basic reproductive number of COVID-19 across United States counties, medRxiv Baqui, 2020, Ethnic and regional variations in hospital mortality from COVID-19 in Brazil: a cross-sectional observational study, Lancet Glob Health, 8, e1018, 10.1016/S2214-109X(20)30285-0 Rocklöv, 2020, High population densities catalyse the spread of COVID-19, J Travel Med, 27, 10.1093/jtm/taaa038 Koopmans, 2020, Assessing the extent of SARS-CoV-2 circulation through serological studies, Nat Med, 26, 1171, 10.1038/s41591-020-1018-x Grasselli, 2020, Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy, JAMA Intern Med, 10.1001/jamainternmed.2020.3539 Liu, 2020, Evaluation of nucleocapsid and spike protein-based enzyme-linked immunosorbent assays for detecting antibodies against SARS-CoV-2, J Clin Microbiol, 58, e00461, 10.1128/JCM.00461-20